Recombinant Human Thioredoxin-1 Protects Macrophages from Oxidized Low-Density Lipoprotein-Induced Foam Cell Formation and Cell Apoptosis |
Zhang, Hui
(Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, the Second Affiliated Hospital of Harbin Medical University)
Liu, Qi (Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, the Second Affiliated Hospital of Harbin Medical University) Lin, Jia-Le (Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, the Second Affiliated Hospital of Harbin Medical University) Wang, Yu (Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, the Second Affiliated Hospital of Harbin Medical University) Zhang, Ruo-Xi (Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, the Second Affiliated Hospital of Harbin Medical University) Hou, Jing-Bo (Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, the Second Affiliated Hospital of Harbin Medical University) Yu, Bo (Department of Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, the Second Affiliated Hospital of Harbin Medical University) |
1 | Xia, X., Li, Y., Su, Q., Huang, Z., Shen, Y., Li, W. and Yu, C. (2015) Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice. Cell Biosci. 5, 23. DOI |
2 | Yamawaki, H., Haendeler, J. and Berk, B. C. (2003) Thioredoxin: a key regulator of cardiovascular homeostasis. Circ. Res. 93, 1029-1033. DOI |
3 | Yoshimoto, R., Fujita, Y., Kakino, A., Iwamoto, S., Takaya, T. and Sawamura, T. (2011) The discovery of LOX-1, its ligands and clinical significance. Cardiovasc. Drugs Ther. 25, 379-391. DOI |
4 | Hsieh, C. C. and Papaconstantinou, J. (2006) Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. FASEB J. 20, 259-268. DOI |
5 | Gleissner, C. A. (2016) Translational atherosclerosis research: from experimental models to coronary artery disease in humans. Atherosclerosis 248, 110-116. DOI |
6 | Guo, R., Su, Y., Liu, B., Li, S., Zhou, S. and Xu, Y. (2014) Resveratrol suppresses oxidised low-density lipoprotein-induced macrophage apoptosis through inhibition of intracellular reactive oxygen species generation, LOX-1, and the p38 MAPK pathway. Cell. Physiol. Biochem. 34, 603-616. |
7 | Janicke, R. U., Sprengart, M. L., Wati, M. R. and Porter, A. G. (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360. DOI |
8 | Holmgren, A. (1985) Thioredoxin. Annu. Rev. Biochem. 54, 237-271. DOI |
9 | Inoue, K., Arai, Y., Kurihara, H., Kita, T. and Sawamura, T. (2005) Over-expression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ. Res. 97, 176-184. DOI |
10 | Ishiyama, J., Taguchi, R., Yamamoto, A. and Murakami, K. (2010) Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells. Atherosclerosis 209, 118-124. DOI |
11 | Kamimoto, Y., Sugiyama, T., Kihira, T., Zhang, L., Murabayashi, N., Umekawa, T., Nagao, K., Ma, N., Toyoda, N., Yodoi, J. and Sagawa, N. (2010) Transgenic mice overproducing human thioredoxin-1, an antioxidative and anti-apoptotic protein, prevents diabetic embryopathy. Diabetologia 53, 2046-2055. DOI |
12 | Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Moriwaki, H., Murase, T., Sawamura, T., Masaki, T., Hashimoto, N. and Kita, T. (1999) Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99, 3110-3117. DOI |
13 | D'Annunzio, V., Perez, V., Boveris, A., Gelpi, R. J. and Poderoso, J. J. (2016) Role of thioredoxin-1 in ischemic preconditioning, postconditioning and aged ischemic hearts. Pharmacol. Res. 109, 24-31. DOI |
14 | Chen, G., Li, X., Huang, M., Li, M., Zhou, X., Li, Y. and Bai, J. (2016) Thioredoxin-1 increases survival in sepsis by inflammatory response through suppressing endoplasmic reticulum stress. Shock 46, 67-74. DOI |
15 | Cohen, J. I., Roychowdhury, S., DiBello, P. M., Jacobsen, D. W. and Nagy, L. E. (2009) Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 49, 1709-1717. DOI |
16 | Cuadrado, A. and Nebreda, A. R. (2010) Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417. |
17 | Dai, M. X., Zheng, X. H., Yu, J., Yin, T., Ma, M. J., Zhang, L., Liu, M., Ma, Y., Liu, L. W., Gao, X., Li, Y., Song, L. Q. and Wang, H. C. (2014) The impact of intermittent and repetitive cold stress exposure on endoplasmic reticulum stress and instability of atherosclerotic plaques. Cell. Physiol. Biochem. 34, 393-404. DOI |
18 | Dunn, S., Vohra, R. S., Murphy, J. E., Homer-Vanniasinkam, S., Walker, J. H. and Ponnambalam, S. (2008) The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem. J. 409, 349-355. DOI |
19 | Liao, X., Sluimer, J. C., Wang, Y., Subramanian, M., Brown, K., Pattison, J. S., Robbins, J., Martinez, J. and Tabas, I. (2012) Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 15, 545-553. DOI |
20 | Laurent, T. C., Moore, E. C. and Reichard, P. (1964) Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from escherichia coli B. J. Biol. Chem. 239, 3436-3444. |
21 | Lin, Y. W., Liu, P. S., Adhikari, N., Hall, J. L. and Wei, L. N. (2015) RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages. J. Mol. Cell. Cardiol. 79, 287-294. DOI |
22 | Luo, Y., Sun, G., Dong, X., Wang, M., Qin, M., Yu, Y. and Sun, X. (2015) Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction. PLoS ONE 10, e0120259. DOI |
23 | Moore, K. J. and Tabas, I. (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355. DOI |
24 | Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J. and Taketo, M. M. (1996) Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev. Biol. 178, 179-185. DOI |
25 | Mehta, J. L., Sanada, N., Hu, C. P., Chen, J., Dandapat, A., Sugawara, F., Satoh, H., Inoue, K., Kawase, Y., Jishage, K., Suzuki, H., Takeya, M., Schnackenberg, L., Beger, R., Hermonat, P. L., Thomas, M. and Sawamura, T. (2007) Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ. Res. 100, 1634-1642. DOI |
26 | Moore, K. J., Sheedy, F. J. and Fisher, E. A. (2013) Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709-721. DOI |
27 | Pirillo, A., Norata, G. D. and Catapano, A. L. (2013) LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013, 152786. |
28 | Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K. and Ichijo, H. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606. DOI |
29 | Powis, G. and Montfort, W. R. (2001) Properties and biological activities of thioredoxins. Annu. Rev. Biophys. Biomol. Struct. 30, 421-455. DOI |
30 | Rusinol, A. E., Thewke, D., Liu, J., Freeman, N., Panini, S. R. and Sinensky, M. S. (2004) AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J. Biol. Chem. 279, 1392-1399. DOI |
31 | Tabas, I. (2010) Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36-46. DOI |
32 | Schaeffer, D. F., Riazy, M., Parhar, K. S., Chen, J. H., Duronio, V., Sawamura, T. and Steinbrecher, U. P. (2009) LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma. J. Lipid Res. 50, 1676-1684. |
33 | Seimon, T. and Tabas, I. (2009) Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. 50 Suppl, S382-S387. DOI |
34 | Tabas, I. (2009) Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid. Redox Signal. 11, 2333-2339. DOI |
35 | Tao, L., Gao, E., Hu, A., Coletti, C., Wang, Y., Christopher, T. A., Lopez, B. L., Koch, W. and Ma, X. L. (2006) Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br. J. Pharmacol. 149, 311-318. DOI |
36 | Wang, B., Tian, S., Wang, J., Han, F., Zhao, L., Wang, R., Ning, W., Chen, W. and Qu, Y. (2015) Intraperitoneal administration of thioredoxin decreases brain damage from ischemic stroke. Brain Res. 1615, 89-97. DOI |
37 | Wang, W. L., Meng, Z. X., Zhou, S. J., Li, C. J., Chen, R., Lv, L., Ma, Z. J., Yu, D. M. and Yu, P. (2013) Reduced beta2-glycoprotein I protects macrophages from ox-LDL-induced foam cell formation and cell apoptosis. Lipids Health Dis. 12, 174. DOI |